ARCHIVES

Phase II Study of Veliparib Improves PFS by 35 Percent

This article is from The Cancer Letter archive.

Vol. 37 No. 10 | October 31, 2014

Download PDF Visit The Full Archive

Related Articles

DCT Moves Fast to Take Control Of Cooperative Groups, Get Multimodality Studies Under Way

October 3, 1975

FDA IND Approval Of New Cancer Drug Is First Based On Phase 1 Clinical Trials In Europe

December 5, 1986

“Confidential and Proprietary” Document Proposes Plan for National Network

February 7, 2014

(8-page issue)

October 4, 2002

GAO Report Finds Increase in Self-Referred Pathology Services

August 9, 2013

Review Panel: NCI Intramural Program Is Too Large, Redundant, Hierarchical

May 19, 1995